Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM

Fig. 1

Characterization of Fe3O4-siPD-L1@M-BV2. A Diagram of the composition of Fe3O4-siPD-L1@M-BV2. B The optimized mass ratio between siPD-L1 and Fe3O4 screened by agarose gel electrophoresis. C Particle size distribution of Fe3O4. D Element mapping analysis diagram of Fe3O4-siPD-L1. E Particle size distribution of Fe3O4-siPD-L1@M-BV2. F SDS-PAGE protein analysis of Fe3O4-siPD-L1@M-BV2. G The protein expressions of CX3CL1, CSF-1, CX3CR1 and CSF-1R in GL261/TR cell, BV2 cell, GL261/TR cell membrane (M-GL261/TR), BV2 cell membrane (M-BV2) and Fe3O4-siPD-L1@M-BV2. H LSCM imaging of Fe3O4-siPD-L1@M-BV2. Green color (FAM) stands for Fe3O4-siPD-L1, and red color (DiI) stands for BV2 cell membrane. I GSH responsive of Fe3O4-siPD-L1@M-BV2 observed by agarose gel electrophoresis. J Stability of siPD-L1 in RNase A observed by agarose gel electrophoresis

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us